BRCA1-associated protein 2 (BRAP2) is known to interact with the kinase suppressor of Ras 1 (KSR1), inhibiting the ERK signal transduction cascade. This study found that an Epstein-Barr virus (EBV) immediate-early protein, Rta, is a binding partner of BRAP2 in yeast and confirmed the binding in vitro by a glutathione S-transferase pull-down assay and in vivo by coimmunoprecipitation in 293(maxi-EBV) cells. Binding studies also showed that Rta and KSR1 interacted with the C-terminal 202 aa region in BRAP2. Additionally, Rta appeared to prevent the binding of KSR1 to BRAP2, activating the ERK signal transduction pathway and the transcription of an EBV immediate-early gene, BZLF1. Activation of the ERK signal transduction pathway by Rta may be critical for the maintenance of the lytic state of EBV.
INTRODUCTIONEpstein-Barr virus (EBV) is a human herpesvirus that infects lymphoid and epithelial cells. Although EBV infection is commonly asymptomatic, infection by this virus also causes infectious mononucleosis (Diehl et al., 1968) and is closely associated with many neoplastic disorders (Einhorn et al., 1970;Gunven et al., 1970;Johansson et al., 1970;Klein et al., 1970). Although EBV typically remains latent after infection of B lymphocytes, the virus must enter a lytic cycle to produce virus particles. During the onset of the lytic cycle, the virus expresses the proteins Rta and Zta, encoded by BRLF1 and BZLF1, respectively, to activate the genes required for the viral lytic cycle (Chevallier-Greco et al., 1986;Chiu et al., 2007;Feederle et al., 2000;Granato et al., 2006;Hardwick et al., 1988;Lu et al., 2006). Although the exact means by which the EBV lytic cycle is activated in vivo is unknown, activation in vitro occurs after latently infected cells are exposed to 12-Otetradecanoylphorbol-13-acetate (TPA), calcium ionophores, transforming growth factor (TGF)-b1 or anti-IgG (Daibata et al., 1990; Faggioni et al., 1986;zur Hausen et al., 1978). TPA, anti-IgG and TGF-b1 are known to activate the ERK signal transduction pathway (Fahmi et al., 2000;Fenton & Sinclair, 1999;Gao et al., 2001;Satoh et al., 1999), which ultimately activates transcription of BZLF1 and the EBV lytic cycle (Borras et al., 1996;Flemington & Speck, 1990).It is known that EBV must express Zta to activate its lytic genes (Chevallier-Greco et al., 1986;Chiu et al., 2007;Feederle et al., 2000). Earlier studies have established that Rta upregulates transcription of the Zta gene, BZLF1 (Adamson et al., 2000;Ragoczy et al., 1998;Zalani et al., 1996). This activation is associated with activation of the p38 and JNK signal transduction pathway, causing the phosphorylation of ATF1/2 and the activation of transcription through an ATF1/ 2 site in the ZII region of the promoter (Adamson et al., 2000). However, the exact means by which Rta activates these signal transduction cascades is unknown. In this study, we used a yeast two-hybrid analysis to show that Rta interacts with BRCA1-associated protein 2 (BRAP2, also known as IMP), a protein that is known to i...